Sign In
Buy PFE
$26.04
+0.345 (+1.34%)
At Close: Jun 05, 2026
My Top 10 Stocks to Buy for 2025
04:05am, Saturday, 21'st Dec 2024
It's that time of year again. I'm not referring to buying gifts and preparing holiday meals -- although that may be part of your agenda too.
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) today announced that the U.S. Food and Drug Administration (FDA) has approved BRAFTOVI® (encorafenib) in combination with cetuximab (marketed as ERB
Why Pfizer (PFE) Dipped More Than Broader Market Today
06:51pm, Thursday, 19'th Dec 2024
Pfizer (PFE) concluded the recent trading session at $25.77, signifying a -0.46% move from its prior day's close.
Pfizer Invites Public to View and Listen to Webcast of February 4 Conference Call with Analysts
10:00am, Thursday, 19'th Dec 2024
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) invites investors and the general public to view and listen to a webcast of a conference call with investment analysts at 10:30 a.m. EST on Tuesday,
Pfizer Could Soar to $36 Per Share, According to a Wall Street Analyst. Is It a Buy at Around $26?
06:07am, Thursday, 19'th Dec 2024
Shares of Pfizer (PFE -2.04%) recently marched higher in response to a dividend payout raise and a forward-looking presentation. Management confirmed the annual revenue and earnings outlook it provide
Roam For the Holidays: Grindr Offers Free Access to Their Popular Travel Feature
06:00am, Thursday, 19'th Dec 2024
WEST HOLLYWOOD, Calif.--(BUSINESS WIRE)--From December 22 to January 2, people on Grindr across the globe can experience Roam, a popular new feature, free of charge.
Pfizer Momentum Shift Makes Me Less Bullish (Technical Analysis)
12:52pm, Wednesday, 18'th Dec 2024
Pfizer Inc.'s technical indicators have shifted from bullish to bearish, with the stock now trading below its 30-week EMA and showing bearish momentum. Volume analysis indicates recent institutional s
Pfizer Stock Up 5% as 2025 Guidance Meets Investor Expectations
10:46am, Wednesday, 18'th Dec 2024
Pfizer projects total revenues between $61.0 and $64.0 billion with EPS in the range of $2.80 to $3.00.
Is Pfizer Stock Undervalued?
09:20am, Wednesday, 18'th Dec 2024
Pfizer stock (NYSE: PFE) was up 5% on Tuesday, December 17, after the company announced an optimistic outlook for 2025. The company expects its revenue to be in the range of $61 billion to $64 billion
3 of the Safest Ultra-High-Yield Dividend Stocks to Buy in 2025
04:51am, Wednesday, 18'th Dec 2024
Arguably the greatest aspect of putting your money to work on Wall Street is that there's no one-size-fits-all strategy to generate wealth. With thousands of publicly traded companies and exchange-tra
Pfizer climbs 4% on 2025 outlook
05:34pm, Tuesday, 17'th Dec 2024
Evan David Seigerman, BMO analyst, joins 'Closing Bell Overtime' to talk Pfizer's 2025 outlook.
Pfizer's 2025 guidance positions company for EPS expansion, says BMO
02:34pm, Tuesday, 17'th Dec 2024
BMO Capital reiterated an Outperform rating and $36 price target on Pfizer, saying that 2025 guidance succeeds in meeting the majority of the firm's expectations outlined in its preview, positioning t
Barclays fact-checked Trump comments on pharmacy benefit managers
01:40pm, Tuesday, 17'th Dec 2024
Barclays analyst Andrew Mok said that while the existential risk to pharmacy benefit managers is low, President-elect Trump's comments yesterday point to additional headline risk and greater support f
Here's why Pfizer (PFE) stock is surging
12:22pm, Tuesday, 17'th Dec 2024
Pfizer (NYSE: PFE) shares rose nearly 3% to $25.98 in premarket trading on December 17 after the pharmaceutical giant released its 2025 financial guidance.
Stock Of The Day: Is Pfizer About To Break Out? Expect A New Uptrend If Resistance Breaks
12:12pm, Tuesday, 17'th Dec 2024
Shares of Pfizer Inc. PFE are making a large move higher Tuesday. But the stock has run into resistance.
